
Simpson Thacher & Bartlett LLP combines regulatory insight with serious litigation firepower across the full spectrum of competition work. The group is led globally by Sara Razi from Washington, DC, whose FTC background underpins the firm’s strength in merger control, investigations, and counseling, alongside John Terzaken, a former DOJ criminal enforcement head also in DC with standout credentials in cartel, fraud, and follow-on litigation. Peter Guryan, operating out of New York, complements this leadership with experience in civil and criminal matters, particularly in high-stakes global transactions. The litigation platform is reinforced by Lynn Neuner and Jonathan Youngwood, both global litigation co-chairs, who bring heavyweight trial and appellate expertise and ensure antitrust matters benefit from the firm’s broader disputes capability, providing additional support from New York. In Washington, DC, Abram Ellis defends clients in class actions and antitrust litigation, particularly in the healthcare sector, but also in industries including food and beverage, chemicals, finance and real estate.
Legal 500 Editorial commentary
Accolades
Client satisfaction: Sector knowledge
Testimonials
Collated independently by Legal 500 research team.
- Abram Ellis is pragmatic and deeply knowledgeable; we often find a way to make new business work while being protective.
- Comprehensive guidance across jurisdictions and activities makes them our go-to global practice for antitrust advisory and litigation.
- Abram Ellis is pragmatic and deeply knowledgeable; we often find a way to make new business work while being protective.
Key clients
- 21st Century Oncology
- Amedisys
- Canadian National Railway Company
- Change Healthcare
- Corsair Capital
- Covestro
- Cross Country Healthcare
- Deutsche Bank
- Dollar General Corp.
- HCA Healthcare
- JPMorgan
- Laborie
Work highlights
Represented Mattress Firm in defeating the FTC’s high-profile challenge to its $4 billion vertical merger with Tempur Sealy.
Represented Deutsche Bank in winning a dismissal in the odd-lots litigation.
Representing Amedisys in resolving DOJ litigation attempting to block its proposed $3.3 billion acquisition by UnitedHealth Group.
Lawyers
Next Generation Partners
Junior partners with significant recognition from clients and peers in the market and key roles on multiple matters.

Practice head
Sara Y. Razi; John Terzaken; Peter Guryan; Lynn K. Neuner; Jonathan K. Youngwood
Other key lawyers
Abram Ellis; Nicholas Ingros
